Jubilant Pharma gets USFDA nod for Symmetrel's generic version

The approved drug, generic version of Symmetrel of Endo, is indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news